Ellington Management Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,900
| Closed | -$440K | – | 492 |
|
|
2020
Q1 | $440K | Buy |
+4,900
| New | +$440K | 0.1% | 253 |
|
|
2018
Q4 | – | Sell |
-2,400
| Closed | -$334K | – | 651 |
|
|
2018
Q3 | $334K | Buy |
+2,400
| New | +$334K | 0.09% | 300 |
|
|
2018
Q1 | – | Sell |
-2,700
| Closed | -$323K | – | 1070 |
|
|
2017
Q4 | $323K | Buy |
+2,700
| New | +$323K | 0.05% | 340 |
|
|
2017
Q3 | – | Sell |
-5,000
| Closed | -$608K | – | 922 |
|
|
2017
Q2 | $608K | Sell |
5,000
-200
| -4% | -$24.3K | 0.09% | 184 |
|
|
2017
Q1 | $630K | Buy |
+5,200
| New | +$630K | 0.02% | 236 |
|
|
2015
Q2 | – | Sell |
-3,000
| Closed | -$520K | – | 950 |
|
|
2015
Q1 | $520K | Buy |
+3,000
| New | +$520K | 0.11% | 271 |
|
|
2013
Q4 | – | Sell |
-6,200
| Closed | -$720K | – | 859 |
|
|
2013
Q3 | $720K | Buy |
+6,200
| New | +$720K | 0.14% | 179 |
|